ClinicalTrials.gg
RecruitingNCT07552896Updated Aug 5, 2026

Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years

An observational study in Agitation and Postoperative Agitation, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 2 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Primary conditionPsychomotor Agitation(the registry's first term)UnverifiedIs this wrong?The registry often attaches Psychomotor Agitation to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
288
Ages
2 Years to 11 Years
Sex
All
01

Study summary

This prospective observational study aims to evaluate the association between daily screen exposure duration and postoperative emergence delirium in children aged 2 to 11 years undergoing elective lower abdominal surgery. Daily screen time will be assessed using a parent-reported questionnaire administered preoperatively. Postoperative emergence delirium will be evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) scale at 5, 10, 15, and 30 minutes after surgery.

The primary outcome is the association between daily screen time and PAED score within the first 30 minutes postoperatively. Secondary outcomes include the associations between PAED score and age at first screen exposure, type of viewed content, parental screen use, passive screen exposure, and the presence of a screen in the child's bedroom. The study is designed to improve understanding of whether screen-related environmental factors are associated with postoperative behavioral recovery in pediatric surgical patients.

Read the detailed description

Postoperative emergence delirium is a common behavioral disturbance in children after general anesthesia and may be associated with delayed recovery, increased distress, and greater need for postoperative management. Environmental and behavioral factors that may influence postoperative agitation are not yet fully understood. Screen exposure has become a major part of early childhood life, and excessive or early exposure has been associated with emotional dysregulation, anxiety-related symptoms, and behavioral difficulties. However, the relationship between daily screen time and postoperative emergence delirium has not been adequately studied.

This study is a prospective, single-center, observational cohort study conducted in children aged 2 to 11 years undergoing elective lower abdominal surgery, including inguinal hernia repair, orchiopexy for undescended testis, and circumcision. After written informed consent is obtained from the parent or legal guardian, a structured questionnaire will be completed in the preoperative waiting area. The questionnaire will collect information on daily screen exposure duration, age at first screen exposure, type of content viewed, parental screen use, passive screen exposure in the home environment, and the presence of a screen in the child's bedroom. Sociodemographic and clinical variables, including age, sex, parental education status, previous surgery or anesthesia history, ASA physical status, and type of surgery, will also be recorded.

No active intervention will be applied. This is a non-interventional observational study in which daily screen exposure duration is the exposure of interest. Participants may be categorized into screen exposure groups for descriptive and comparative analyses, but the primary analysis will evaluate the association between daily screen time as a continuous variable and PAED score.

Postoperative emergence delirium will be assessed using the Pediatric Anesthesia Emergence Delirium scale. PAED scoring will be performed by the study investigator at 5, 10, 15, and 30 minutes postoperatively, after the child has recovered sufficiently for assessment. Higher PAED scores indicate more severe emergence delirium symptoms.

The primary outcome measure is the association between daily screen time and PAED score within the first 30 minutes postoperatively. Secondary outcome measures include the associations between PAED score and age at first screen exposure, type of screen content, parental screen use, passive screen exposure, and the presence of a screen in the bedroom. Additional exploratory analyses may examine the influence of demographic and clinical variables on PAED scores.

Children will be excluded if they receive premedication, undergo emergency surgery or reoperation, have developmental delay, neurodevelopmental or psychiatric disorders, visual or hearing impairment interfering with behavioral assessment, current use of sedative, antipsychotic, or antiepileptic medications, anticipated postoperative intensive care requirement, or incomplete parent-reported questionnaire data.

The findings of this study may help identify screen-related factors associated with postoperative emergence delirium and may contribute to improved preoperative risk assessment and family guidance in pediatric surgical practice.

02

Conditions studied

  • Agitation
  • Postoperative Agitation

Browse trials for

03

In context

Psychomotor Agitation Unverified

231 studies on the registry are indexed under Psychomotor Agitation; 28 are open to participants now.

This study's planned enrollment of 288 is above the median of 138 across 31 observational studies indexed under Psychomotor Agitation.

Browse Psychomotor Agitation studies →

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 225 studies on the registry; 35 are open to participants now.

Compared within Psychomotor Agitation, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
2 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population consists of children aged 2-11 years undergoing elective lower abdominal surgery, including inguinal hernia repair, orchiopexy for undescended testis, and circumcision, at a tertiary care hospital. Participants are classified according to daily screen exposure duration based on parent-reported data. Only patients meeting the inclusion criteria and whose parents provide written informed consent will be enrolled. Children with developmental, neurological, or psychiatric disorders, or those receiving premedication, will be excluded to ensure reliable behavioral assessment using the PAED scale.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 2 to 11 years
  • Scheduled for elective lower abdominal surgery
  • Planned procedures include inguinal hernia repair, orchiopexy for undescended testis, or circumcision
  • (ASA) physical status I-II
  • Parent or legal guardian able to provide written
  • Parent or legal guardian able to complete the study questionnaire

Exclusion criteria

Exclusion Criteria:

  • Planned or administered premedication before surgery
  • Emergency surgery
  • Reoperation
  • Developmental delay, neurodevelopmental disorder, or known psychiatric disease
  • Visual or hearing impairment that may interfere with behavioral assessment
  • Current use of sedative, antipsychotic, or antiepileptic medication
  • Anticipated postoperative intensive care unit requirement
  • Incomplete or unreliable parent-reported questionnaire data
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
288 participants (estimated)
Patient registry
No

Groups and cohorts

  • Low Screen Exposure (<2 Hours/Day)

    Children aged 2-11 years undergoing elective lower abdominal surgery with daily screen exposure of less than 2 hours, as reported by parents. Postoperative emergence delirium will be assessed using the PAED score.

    Diagnostic Test: Daily Screen Exposure Duration

  • High Screen Exposure (>2 Hours/Day)

    Children aged 2-11 years undergoing elective lower abdominal surgery with daily screen exposure of more than 2 hours, as reported by parents. Postoperative emergence delirium will be assessed using the PAED score.

    Diagnostic Test: Daily Screen Exposure Duration

Interventions

  • Diagnostic testDaily Screen Exposure Duration

    This is a non-interventional observational study. The exposure of interest is the daily screen time duration of children aged 2-11 years, as reported by parents. Participants are categorized into two groups based on screen exposure (\<2 hours/day and \>2 hours/day). No active intervention is applied.

06

What researchers measure

Primary outcomes

  1. Association Between Daily Screen Time and PAED Score

    Correlation between daily screen exposure duration (continuous variable) and PAED score.

    Time frame: Within the first 30 minutes after emergence from anesthesia

Secondary outcomes

  1. Age at First Screen Exposure and Emergence Delirium

    Association between age at first screen exposure and PAED score.

    Time frame: Within the first 30 minutes postoperatively

  2. Influence of Sociodemographic Factors on Emergence Delirium

    Assessment of the effect of age, sex, parental education level, and family structure on PAED scores.

    Time frame: Within the first 30 minutes postoperatively

  3. Type of Screen Content and Emergence Delirium

    Evaluation of the relationship between type of content viewed (cartoons, games, educational, mixed) and PAED score.

    Time frame: Within the first 30 minutes postoperatively

  4. Parental Screen Use and Emergence Delirium

    Association between parental daily screen use and PAED score.

    Time frame: Within the first 30 minutes postoperatively

  5. Passive Screen Exposure and Emergence Delirium

    Evaluation of the effect of background screen exposure in the home environment on PAED score.

    Time frame: Within the first 30 minutes postoperatively

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for May 2027, 12 months after the start.

Of 19 observational studies under Psychomotor Agitation, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 32. This study's planned 12 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2026
First posted
Apr 27, 2026
StartActual
May 1, 2026
Primary completionEst.
May 1, 2027
CompletionEst.
May 2, 2027
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07552896
Responsible party
Engin Ihsan Turan (principal investigator, Kanuni Sultan Suleyman Training and Research Hospital) — Principal investigator
First posted
Apr 27, 2026
Start date
May 1, 2026
Primary completion
May 1, 2027 (estimated)
Completion
May 2, 2027 (estimated)
Last update
Aug 5, 2026

Study contacts

Engin ihsan Turan, principal investigator
Contact
enginihsan@hotmail.com
+905382431114

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion